TherapeuticsMD, Inc. (TXMD): $1.20

-0.01 (-0.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

TherapeuticsMD Inc (TXMD) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering TXMD.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
6 $10 $3 $6 $1.29 365.12%

The Trend in the Analyst Price Target


Over the past 162 days, TXMD's average price target has gone down $0.57.

Over the past 13 months, TXMD's average upside potential has been 367.45%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-13 6 10 3.0 6.00 1.320 354.55%
2021-06-05 6 10 3.0 6.00 1.210 395.87%
2021-05-22 6 10 3.0 6.00 1.230 387.8%
2021-05-15 6 10 3.0 6.00 1.050 471.43%
2021-05-08 6 10 3.0 6.00 1.090 450.46%
2021-04-25 6 10 3.0 6.17 1.170 427.35%
2021-04-17 6 10 3.0 6.17 1.185 420.68%
2021-04-10 6 10 3.0 6.17 1.320 367.42%
2021-04-03 6 10 3.0 6.17 1.390 343.88%
2021-03-20 6 10 3.0 6.17 1.540 300.65%
2021-03-13 6 10 3.0 6.17 1.590 288.05%
2021-03-06 6 10 3.0 6.17 1.370 350.36%
2021-02-27 6 10 3.0 6.67 1.520 338.82%
2021-02-20 6 10 3.0 6.67 1.770 276.84%
2021-02-13 6 10 3.0 6.67 1.910 249.21%
2021-02-06 6 10 3.0 6.67 1.900 251.05%
2021-01-30 7 10 3.0 6.29 1.650 281.21%
2021-01-23 7 10 3.0 6.43 1.500 328.67%
2021-01-16 7 10 3.0 6.43 1.380 365.94%
2021-01-09 7 10 3.0 6.57 1.330 393.98%
2021-01-02 7 10 3.0 6.57 1.210 442.98%
2020-12-26 8 10 1.2 5.90 1.190 395.8%
2020-12-19 8 10 1.2 5.90 1.220 383.61%
2020-12-09 8 13 1.2 6.90 1.160 494.83%
2020-12-07 8 13 1.2 6.90 1.260 447.62%
2020-11-28 8 13 1.2 6.90 1.370 403.65%
2020-11-09 8 13 1.2 6.90 1.520 353.95%
2020-10-23 7 13 1.2 6.46 1.480 336.49%
2020-08-29 8 13 1.2 6.90 1.490 363.09%
2020-08-06 8 13 1.2 6.90 1.610 328.57%
2020-07-22 8 13 1.2 7.15 1.990 259.3%
2020-07-14 8 13 1.2 7.15 1.490 379.87%
2020-07-05 7 13 1.2 6.74 1.390 384.89%
2020-06-17 8 13 1.2 7.15 1.245 474.3%
2020-06-13 8 13 1.2 7.28 NA NA%
2020-05-08 8 13 1.2 7.28 NA NA%

TXMD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.3 2 3 0 0 0 5

The Trend in the Broker Recommendations


Over the past 48 weeks, TXMD's average broker recommendation rating worsened by 0.17.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TXMD as an investment opportunity.

  • TXMD has a lower variance in analysts' estimates than 2.89% of all US stocks.
  • TXMD has a higher upside potential (average analyst target price relative to current price) than 97.06% of all US stocks.
  • TXMD has a greater average analyst price target than 10.9% of all US stocks.
  • TXMD has a greater number of analysts covering the stock than 79.4% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to TherapeuticsMD Inc are LOGC, CLRB and ARAV.

Is TXMD a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6905 seconds.